T. Hassell

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children.

J. Treanor, S. Halperin, M. Germain, 2002, Vaccine.

The use of glutamine-free media for the growth of three cell lines in microcarrier culture

M. Butler, T. Hassell, I. C. Allen, 1987 .

Recent developments in vertebrate cell culture technology.

S. J. Parulekar, T. Hassell, S. C. Tripathi, 1992, International review of cytology.

Adaptation to non-ammoniagenic medium and selective substrate feeding lead to enhanced yields in animal cell cultures.

M. Butler, T. Hassell, 1990, Journal of cell science.

Growth inhibition in animal cell culture

M. Butler, M Butler, T. Hassell, 1991, Applied biochemistry and biotechnology.

Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate

W. Schief, S. Menis, V. Tsvetnitsky, 2022, bioRxiv.

Rapid cGMP manufacturing of COVID‐19 monoclonal antibody using stable CHO cell pools

D. Burton, M. Feinberg, J. Jardine, 2021, Biotechnology and bioengineering.

THE EFFECT OF METABOLIC BY-PRODUCTS ON ANIMAL CELLS IN CULTURE

M. Butler, T. Hassell, C. Doyle, 1991 .